Insurance Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Insurance Press Releases.

Press releases published on June 12, 2026

Jun. 12, 2026

The Guardian Group, LLC announces Fellowship Trained and Board Certified Psychiatrist: Leila Hariri, MD, QME

Indeterminate EIN Presswire

Jun. 12, 2026

Father's Story Inspires Chicago Attorney's Free Illinois Workers' Comp Guide

Indeterminate EIN Presswire

Jun. 12, 2026

The Guardian Group, LLC announces Fellowship Trained Psychiatrist: Camellia Clark, MD, QME

Indeterminate EIN Presswire

Jun. 12, 2026

The Guardian Group, LLC announces Board-Certified Psychiatrist: Matthew Bojanowski, MD, QME

Indeterminate EIN Presswire

Jun. 12, 2026

KLAS Research Validates Real-World ROI of Onpoint's Iris Medical Agent AI Platform: A True Workforce Extension

Indeterminate EIN Presswire

Jun. 12, 2026

Mangrove Property Insurance Company to Attend FAIA 2026 Annual Convention

Indeterminate EIN Presswire

Jun. 12, 2026

Le Groupe UNMI poursuit sa croissance en 2025

Indeterminate EIN Presswire

Jun. 12, 2026

ASI clarifie son positionnement et accompagne l’autonomie de MOCA

Indeterminate EIN Presswire

Jun. 12, 2026

MERIDIAN BARRIERS AGAIN EFFECTIVE IN PROTECTING CROWDS FROM ALLEGED DRUNK DRIVER

Indeterminate EIN Presswire

Jun. 12, 2026

SpaceX IPO Project Unlimited (Weiss Ratings' Michael Robinson Disruptors & Dominators Newsletter) Elon's Trillion Dollar Plan to Save AI

Indeterminate GlobeNewswire

Jun. 12, 2026

Balfour Capital Group on AI and Reputation. A Powerful Tool That Still Needs Human Judgement

Indeterminate EIN Presswire

Jun. 12, 2026

CORRECTION -- Leverage Shares by Themes Launches 2X Long and -2X Short SpaceX ETFs with 0.75% Fee to Meet Unprecedented Retail Demand

Indeterminate GlobeNewswire

Jun. 12, 2026

Julian Barnes Named Laureate of the 2026 Fitzgerald Prize

Indeterminate GlobeNewswire

Jun. 12, 2026

Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes

Indeterminate GlobeNewswire

Jun. 12, 2026

Communiqué de presse : Le Tzield de Sanofi approuvé aux États-Unis comme première thérapie modificatrice de la maladie pour les patients récemment diagnostiqués avec un diabète de type 1 au stade 3

Indeterminate GlobeNewswire

Jun. 12, 2026

WSE Investor News: If You Have Suffered Losses in Wise Group plc (NASDAQ: WSE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire

Jun. 12, 2026

ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages Commvault Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CVLT

Indeterminate GlobeNewswire

Jun. 12, 2026

Avicanna Announces Closing of Non-Brokered Private Placement

Indeterminate GlobeNewswire

Jun. 12, 2026

Gencor Releases Second Quarter Fiscal 2026 Results

Indeterminate GlobeNewswire

Jun. 12, 2026

Heartland Express, Inc. Declares Regular Quarterly Dividend

Indeterminate GlobeNewswire